JILL BRANT: Open Payments
NPI 1528474541 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,011 in 122 payments from 19 companies in 2025. Trend: 2023 $830 · 2024 $2,310 · 2025 $2,011
Food & beverage: $2,011
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $450 |
| Novo Nordisk Inc | 16 | $370 |
| AstraZeneca Pharmaceuticals LP | 10 | $250 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $148 |
| Amgen Inc. | 9 | $140 |
| Lilly USA, LLC | 8 | $129 |
| Exact Sciences Corporation | 7 | $110 |
| Phathom Pharmaceuticals, Inc. | 5 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| PFIZER INC. | 3 | $55 |
Products named: Wegovy, AIRSUPRA, VRAYLAR, QULIPTA, XIFAXAN, JARDIANCE, The Cologuard Plus Collection Kit, UBRELVY.
Industry payments across PA — which companies pay providers there.
